Stimulation of insulin signaling and inhibition of JNK-AP1 activation protect cells from amyloid-β-induced signaling dysregulation and inflammatory response
- PMID: 24346217
- DOI: 10.3233/JAD-131949
Stimulation of insulin signaling and inhibition of JNK-AP1 activation protect cells from amyloid-β-induced signaling dysregulation and inflammatory response
Abstract
One of the hallmarks of Alzheimer's disease (AD) is the accumulation and deposition of amyloid-β (Aβ) peptides in the brain and cerebral vasculature. Aβ evokes neuroinflammation and has been implicated in insulin signaling disruption and JNK-AP1 activation, contributing to AD neuropathologies including oxidative injury and vascular insufficiencies. In this study we aim to better understand the protective mechanisms of insulin signaling and JNK-AP1 inhibition on the adverse effects of Aβ. Four-hour treatment of hCMEC/D3, the immortalized human brain endothelial cells (iHBEC), with Aβ1-42 resulted in significant c-Jun phosphorylation, oxidative stress, and cell toxicity. Concurrent treatment with Aβ1-42 and insulin or Aβ1-42 and JNK inhibitor SP600125 significantly improved cell viability. Cytokine array on conditioned media showed that insulin and SP600125 strongly reduced all Aβ1-42-induced cytokines. ELISA confirmed the protective effect of insulin and SP600125 on Aβ-induced expression of interleukin (IL)-8 and Growth related oncogene-α (Gro-α). qRT-PCR revealed that insulin and SP600125 protected iHBEC from Aβ1-42-induced inflammatory gene expression. Transcription factor profiling showed that treatment of iHBEC with Aβ1-42, insulin, or SP600125 alone or in combination resulted in profound changes in modulating the activities of multiple transcription factors and relevant pathways, some of which were validated by western blot. Insulin treatment and JNK inhibition in vitro synergistically reduced c-Jun phosphorylation and thus JNK-AP1 signaling activation. The study suggests that activation of insulin and blocking of JNK-AP1 signaling inhibits Aβ-induced dysregulation of insulin signaling and inflammatory response.
Keywords: Alzheimer's disease; JNK-AP1 signaling; amyloid-β peptides; inflammatory response insulin signaling.
Similar articles
-
Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.Neurobiol Dis. 2009 Apr;34(1):95-106. doi: 10.1016/j.nbd.2008.12.007. Epub 2008 Dec 31. Neurobiol Dis. 2009. PMID: 19162185 Free PMC article.
-
Transglutaminase 2 is involved in amyloid-beta1-42-induced pro-inflammatory activation via AP1/JNK signalling pathways in THP-1 monocytes.Amino Acids. 2017 Mar;49(3):659-669. doi: 10.1007/s00726-016-2366-1. Epub 2016 Nov 18. Amino Acids. 2017. PMID: 27864692
-
The role of TLR2/JNK/NF-κB pathway in amyloid β peptide-induced inflammatory response in mouse NG108-15 neural cells.Int Immunopharmacol. 2013 Nov;17(3):880-4. doi: 10.1016/j.intimp.2013.09.016. Epub 2013 Oct 12. Int Immunopharmacol. 2013. PMID: 24126115
-
Signaling mechanisms underlying Abeta toxicity: potential therapeutic targets for Alzheimer's disease.CNS Neurol Disord Drug Targets. 2006 Jun;5(3):355-61. doi: 10.2174/187152706784111515. CNS Neurol Disord Drug Targets. 2006. PMID: 16787235 Review.
-
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.Cell Mol Neurobiol. 2016 Mar;36(2):155-65. doi: 10.1007/s10571-015-0256-9. Epub 2015 Sep 2. Cell Mol Neurobiol. 2016. PMID: 26328781 Free PMC article. Review.
Cited by
-
Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?J Alzheimers Dis. 2015;46(1):35-53. doi: 10.3233/JAD-142976. J Alzheimers Dis. 2015. PMID: 25720414 Free PMC article. Review.
-
Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease.Front Aging Neurosci. 2019 Apr 24;11:88. doi: 10.3389/fnagi.2019.00088. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31068799 Free PMC article. Review.
-
The protective effect of Epimedii Folium and Curculiginis Rhizoma on Alzheimer's disease by the inhibitions of NF-κB/MAPK pathway and NLRP3 inflammasome.Oncotarget. 2017 Jul 4;8(27):43709-43720. doi: 10.18632/oncotarget.12574. Oncotarget. 2017. PMID: 28582770 Free PMC article.
-
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease.Front Pharmacol. 2016 Jan 12;6:321. doi: 10.3389/fphar.2015.00321. eCollection 2015. Front Pharmacol. 2016. PMID: 26793112 Free PMC article. Review.
-
sTREM2 Differentially Affects Cytokine Expression in Myeloid-Derived Cell Models via MAPK-JNK Signaling Pathway.Biology (Basel). 2024 Jan 30;13(2):87. doi: 10.3390/biology13020087. Biology (Basel). 2024. PMID: 38392305 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous